Cargando…

Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology

Iron chelating drugs are primarily and widely used in the treatment of transfusional iron overload in thalassaemia and similar conditions. Recent in vivo and clinical studies have also shown that chelators, and in particular deferiprone, can be used effectively in many conditions involving free radi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kontoghiorghe, Christina N., Kolnagou, Annita, Kontoghiorghes, George J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332094/ https://www.ncbi.nlm.nih.gov/pubmed/26610453 http://dx.doi.org/10.3390/molecules201119725

Ejemplares similares

New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications
por: Kontoghiorghes, George J., et al.
Publicado: (2021)

Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications
por: Kontoghiorghes, George J., et al.
Publicado: (2020)

Transfusion-Related Acute Lung Injury (TRALI) in two Thalassaemia Patients Caused by the Same Multiparous Blood Donor
por: Kolnagou, Annita, et al.
Publicado: (2017)

The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia
por: Kontoghiorghes, George J., et al.
Publicado: (2020)

Conventional and Unconventional Approaches for Innovative Drug Treatments in COVID-19: Looking Outside of Plato’s Cave
por: Kontoghiorghes, George J., et al.
Publicado: (2021)

Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases
por: Kontoghiorghes, George J., et al.
Publicado: (2020)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
por: Kontoghiorghe, Christina N, et al.
Publicado: (2016)

Iron imbalance in cancer: Intersection of deficiency and overload
por: Basak, Tulika, et al.
Publicado: (2022)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Questioning Established Theories and Treatment Methods Related to Iron and Other Metal Metabolic Changes, Affecting All Major Diseases and Billions of Patients
por: Kontoghiorghes, George J.
Publicado: (2022)

Iron overload disorders
por: Hsu, Christine C., et al.
Publicado: (2022)

Body iron metabolism and pathophysiology of iron overload
por: Kohgo, Yutaka, et al.
Publicado: (2008)

Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications
por: Kontoghiorghes, George J.
Publicado: (2023)

Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy
por: Alves, Francesca M., et al.
Publicado: (2022)

Does Pathological Iron Overload Impair the Function of Human Lungs?
por: Ganz, Tomas
Publicado: (2017)

The Role of Iron and Iron Overload in Chronic Liver Disease
por: Milic, Sandra, et al.
Publicado: (2016)

Iron regulation by hepatocytes and free radicals
por: Takami, Taro, et al.
Publicado: (2011)

What is new in iron overload?
por: Vermylen, Christiane
Publicado: (2007)

Inherited Disorders of Iron Overload
por: Pantopoulos, Kostas
Publicado: (2018)

Iron overload and liver cancer
por: Molina-Sánchez, Pedro, et al.
Publicado: (2019)

Oral manifestations of iron imbalance
por: Anne Marie, Uwitonze, et al.
Publicado: (2023)

Effect of Iron Overload and Iron Deficiency on Liver Hemojuvelin Protein
por: Krijt, Jan, et al.
Publicado: (2012)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Differences between the European Union and United States of America in Drug Regulatory Affairs Affect Global Patient Safety Standards and Public Health Awareness: The Case of Deferasirox and Other Iron Chelating Drugs
por: Kontoghiorghes, George J.
Publicado: (2021)

Deferiprone and Iron–Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects
por: Kontoghiorghes, George J.
Publicado: (2023)

Effects of Exogenous Antioxidants on Dietary Iron Overload
por: Asare, George A., et al.
Publicado: (2009)

Iron Overload in Gastric Mucosa: Underdiagnosed Condition Rarely Documented in Clinical and Pathology Reports
por: Onorati, Monica, et al.
Publicado: (2020)

New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer
por: Kontoghiorghes, George J.
Publicado: (2022)

Iron Overload in Sickle Cell Disease
por: Raghupathy, Radha, et al.
Publicado: (2010)

Prooxidant Mechanisms in Iron Overload Cardiomyopathy
por: Cheng, Ching-Feng, et al.
Publicado: (2013)

Educational Case: Iron Overload and Hemochromatosis
por: Borowitz, Michael J., et al.
Publicado: (2018)

Cellular Electrophysiology of Iron-Overloaded Cardiomyocytes
por: Siri-Angkul, Natthaphat, et al.
Publicado: (2018)

Response to iron overload in cultured hepatocytes
por: Chen, Hsuan-Ju, et al.
Publicado: (2020)

Role of Flavonoids in the Treatment of Iron Overload
por: Wang, Xiaomin, et al.
Publicado: (2021)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study
por: Rostoker, Guy, et al.
Publicado: (2015)

Effects of digoxin on cardiac iron content in rat model of iron overload
por: Nasri, Hamid Reza, et al.
Publicado: (2016)

Pathogenic Mechanisms Underlying Iron Deficiency and Iron Overload: New Insights for Clinical Application
por: Kotze, MJ, et al.
Publicado: (2009)

The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Weber, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r2sjqglnpuj34ba1uo4jjvvmn1